Vascular endothelial growth factor (VEGF) and its role in the central nervous system: A new element in the neurotrophic hypothesis of antidepressant drug action
Abstract
Vascular endothelial growth factor (VEGF) is a well-known cellular mitogen, and a vascular growth factor and permeability regulator. It participates in physiological and pathological processes of angiogenesis and in the development of lymphatic vessels. In addition to the proangiogenic activity, studies of recent years have revealed neurotrophic and neuroprotective potential of VEGF both in the peripheral and central nervous system. VEGF directly influences Schwann cells, neuronal progenitor cells, astrocytes and microglia. This factor plays an import role in developmental processes of the nervous tissue since it is implicated in neurogenesis and the regulation of neuronal development, and in the differentiation and formation of vessels in the brain. VEGF elicits its biological effect via an interaction with three VEGF receptor subtypes: VEGFR1, VEGFR2 and VEGFR3. In the nervous system, VEGFR2 signaling prevails. VEGF as a trophic factor, influencing both vascular endothelial cells and brain cells is a focus of the studies on neuropsychiatric disorders and psychotropic drug action. Antidepressant drugs were shown to induce hippocampal expression of VEGF. In addition, the experiments in animals models of depression have demonstrated that VEGFR2 signaling is indispensable for cellular and behavioral response to antidepressant drugs. Acquiring a deeper knowledge into the signaling pathways engaged in neurogenic and behavioral VEGF actions can unravel new targets for more efficient and quick acting antidepressant drugs.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
VEGF could be involved in the connection between COVID-19, major depressive disorder and purinergic signaling.
“Thus, although VEGF involvement in major depressive disorder is controversially discussed [169, 170], this growth factor could be involved in the connection between COVID-19, major depressive disorder and purinergic signaling.”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [170]
Cites
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,540 · see citing works
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvořàk, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,969 · see citing works
Vascular endothelial growth factor (VEGF) and its receptors
Neufeld, G., Cohen, T., Gengrinovitch, S., & Gluzman‐Poltorak, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,488 · see citing works
VEGF receptor signalling ? in control of vascular function
Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1911 · Cited by 3,122 · see citing works
Vascular endothelial growth factor (VEGF) stimulates neurogenesis <i>in vitro</i> and <i>in vivo</i>
Jin, K., Zhu, Y., Sun, Y., Mao, X. O., Xie, L., & Greenberg, D. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182296499 · Cited by 1,507 · see citing works
VEGF enhances angiogenesis and promotes blood–brain barrier leakage in the ischemic brain
Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N. V., & Chopp, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9369 · Cited by 1,296 · cited 1× · see citing works
“Cellular stress induced, for instance, by hypoglycemia, low pH, oxidative stress, may be another activator of VEGF expression (Zhang et al., 2000).”
BackgroundVascular Endothelial Growth Factor
Ferrara, N. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179663 · Cited by 1,283 · see citing works
Blood Vessel Formation: What Is Its Molecular Basis?
Folkman, J., & D'Amore, P. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81810-3 · Cited by 1,227 · see citing works
The Biology of Vascular Endothelial Growth Factor
Ferrara, N. (1997) · Endocrine Reviews · doi:10.1210/er.18.1.4 · Cited by 1,225 · see citing works
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317977 · Cited by 1,189 · see citing works
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A. V., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17977 · Cited by 1,181 · see citing works
Cursiefen, C., Chen, L., Borges, L. P., Jackson, D. G., Cao, J., Radziejewski, C. H., D'Amore, P. A., Dana, M. R., Wiegand, S. J., & Streilein, J. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20465 · Cited by 1,054 · see citing works
Holmes, K., Roberts, O. L., Thomas, A. M., & Cross, M. J. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.05.013 · Cited by 1,020 · see citing works
Cross, M. J., & Claesson‐Welsh, L. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01676-x · Cited by 1,008 · see citing works
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
Robinson, C. J., & Stringer, S. E. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.853 · Cited by 944 · see citing works
VEGF-receptor signal transduction
Cross, M. J., Dixelius, J., Matsumoto, T., & Claesson, L. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00193-2 · Cited by 864 · see citing works
VEGF is necessary for exercise‐induced adult hippocampal neurogenesis
Fabel, K., Fabel, K., Tam, B., Kaufer, D., Baiker, A., Simmons, N., Kuo, C. J., & Palmer, T. D. (2003) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2003.03041.x · Cited by 861 · see citing works
Increased neurogenesis in a model of electroconvulsive therapy
Madsen, T. M., Treschow, A., Bengzon, J., Bolwig, T. G., Lindvall, O., & Tingström, A. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00228-6 · Cited by 765 · see citing works
Quinn, T. P., Peters, K. G., de Vries, C. J. M., Ferrara, N., & Williams, L. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.16.7533 · Cited by 754 · see citing works
Mukouyama, Y., Shin, D., Britsch, S., Taniguchi, M., & Anderson, D. J. (2002) · Cell · doi:10.1016/s0092-8674(02)00757-2 · Cited by 658 · see citing works
VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection
Storkebaum, E., Lambrechts, D., & Carmeliet, P. (2004) · BioEssays · doi:10.1002/bies.20092 · Cited by 505 · see citing works
Role and Therapeutic Potential of VEGF in the Nervous System
de Almodóvar, C. R., Lambrechts, D., Mazzone, M., & Carmeliet, P. (2009) · Physiological Reviews · doi:10.1152/physrev.00031.2008 · Cited by 443 · see citing works
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
Warner-Schmidt, J. L., & Duman, R. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610282104 · Cited by 438 · see citing works
VEGF signalling: integration and multi-tasking in endothelial cell biology
Zachary, I. C. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311171 · Cited by 430 · see citing works
Serotonin4 (5-HT4) Receptor Agonists Are Putative Antidepressants with a Rapid Onset of Action
Lucas, G., Rymar, V. V., Du, J., Mnie‐Filali, O., Bisgaard, C. F., Manta, S., Lambás‐Señas, L., Wiborg, O., Haddjeri, N., Piñeyro, G., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.041 · Cited by 360 · see citing works
Wick, A., Wick, W., Waltenberger, J. L., Weller, M., DICHGANS, J., & Schulz, J. B. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06401.2002 · Cited by 283 · see citing works
New roles for VEGF in nervous tissue?beyond blood vessels
Rosenstein, J. M. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.022 · Cited by 281 · see citing works
Ogunshola, O. O., Antic, A., Donoghue, M. J., Fan, S.-Y., Kim, H., Stewart, W. B., Jr., Madri, J. A., & Ment, L. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111085200 · Cited by 268 · see citing works
Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders
Carmeliet, P., & Storkebaum, E. (2002) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2001.0290 · Cited by 249 · see citing works
Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy
Schratzberger, P., Schratzberger, G., Silver, M., Curry, C., Kearney, M., Magner, M., Alroy, J., Adelman, L. S., Weinberg, D. H., Ropper, A. H., et al. (2000) · Nature Medicine · doi:10.1038/74664 · Cited by 247 · see citing works
Adult hippocampal neurogenesis and related neurotrophic factors
Lee, E., & Son, H. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.5.239 · Cited by 240 · see citing works
Segi‐Nishida, E., Warner‐Schmidt, J. L., & Duman, R. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710858105 · Cited by 223 · see citing works
Rosenstein, J. M., Mani, N., Khaibullina, A., & Krum, J. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11036.2003 · Cited by 220 · see citing works
Bergström, A., Jayatissa, M. N., Mørk, A., & Wiborg, O. (2007) · Brain Research · doi:10.1016/j.brainres.2007.12.025 · Cited by 195 · see citing works
Guidance of vascular and neural network formation
Eichmann, A., le Noble, F., Autiero, M., et al. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.01.008 · Cited by 186 · see citing works
Mechanisms of resistance to antiangiogenesis therapy
Azam, F., Mehta, S., & Harris, A. L. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.020 · Cited by 179 · see citing works
Zhu, Y., Jin, K., Mao, X. O., & Greenberg, D. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0515com · Cited by 177 · see citing works
Expression of vascular endothelial growth factor and its receptors in rat neural stem cells
Maurer, M. H., Tripps, W. K. C., Feldmann, R., & Kuschinsky, W. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00407-5 · Cited by 151 · see citing works
VEGF as a potential target for therapeutic intervention in depression
Warner‐Schmidt, J. L., & Duman, R. S. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.10.013 · Cited by 150 · see citing works
Greene, J., Banasr, M., Lee, B., Warner-Schmidt, J., & Duman, R. S. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.68 · Cited by 143 · see citing works
Li, B., Xu, W., Luo, C., Gozal, D., & Liu, R. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00025-1 · Cited by 141 · see citing works
Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor
Sun, F., & Guo, X. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20321 · Cited by 137 · see citing works
Proia, P., Schiera, G., Mineo, M., Ingrassia, A. M. R., Santoro, G., Savettieri, G., & Liegro, I. D. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.21.1.63 · Cited by 133 · see citing works
Manoonkitiwongsa, P. S., Schultz, R. L., McCreery, D. B., Whitter, E. F., & Lyden, P. D. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000126236.54306.21 · Cited by 131 · see citing works
McCloskey, D. P., Croll, S. D., & Scharfman, H. E. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2577-05.2005 · Cited by 121 · see citing works
Vascular endothelial growth factor promotes neurite maturation in primary CNS neuronal cultures
Khaibullina, A. A., Rosenstein, J. M., & Krum, J. M. (2004) · Developmental Brain Research · doi:10.1016/j.devbrainres.2003.09.022 · Cited by 114 · see citing works
Kahl, K. G., Bens, S., Ziegler, K. J., Rudolf, S., Kordon, A., DIBBELT, L., & Schweiger, U. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.09.016 · Cited by 112 · see citing works
Vascular endothelial growth factor and the nervous system
Brockington, A., Lewis, C. E., Wharton, S. B., & Shaw, P. J. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00600.x · Cited by 112 · see citing works
Iga, J., Ueno, S., Yamauchi, K., Numata, S., Shibuya‐Tayoshi, S., Kinouchi, S., Nakataki, M., Song, H., Hokoishi, K., Tanabe, H., et al. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.12.011 · Cited by 105 · see citing works
Kim, B. W., Choi, M. L., Kim, Y.-S., Park, H., Lee, H., Yun, C., Kim, E. J., Choi, J.-S., Kim, S., Rhim, H., et al. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.12.009 · Cited by 104 · see citing works
Wada, T., Haigh, J. J., Ema, M., Hitoshi, S., Chaddah, R., Rossant, J., Nagy, A., & van der Kooy, D. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0526-06.2006 · Cited by 100 · see citing works
Role of neural guidance signals in blood vessel navigation
Autiero, M., Smet, F. D., CLAES, F., & Carmeliet, P. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.09.013 · Cited by 94 · see citing works
Harms, K. M., Li, L., & Cunningham, L. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009767 · Cited by 89 · see citing works
Joo, J., Kim, B., Lee, J.-S., Park, J.-Y., Kim, S., Yun, Y.-J., Lee, S.-H., Lee, S., Rhim, H., & Son, H. (2007) · Journal of Cell Science · doi:10.1242/jcs.002154 · Cited by 87 · see citing works
Mani, N., Khaibullina, A., Krum, J. M., & Rosenstein, J. M. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.12.022 · Cited by 84 · see citing works
Viikki, M., Anttila, S. A. K., Kampman, O., Illi, A., Huuhka, M., Setälä-Soikkeli, E., Mononen, N., Lehtimäki, T. J., & Leinonen, E. V. J. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.04.039 · Cited by 75 · see citing works
Lee, H., Chang, Y., Tu, Y., & Huang, C. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5497-08.2009 · Cited by 74 · see citing works
VEGF serum levels in depressed patients during SSRI antidepressant treatment
Ventriglia, M., Zanardini, R., Pedrini, L., Placentino, A., Nielsen, M. G., Gennarelli, M., & Bocchio‐Chiavetto, L. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.009 · Cited by 69 · see citing works
Nakamura, K., Tan, F., Li, Z., et al. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.12.002 · Cited by 67 · see citing works
Tamburella, A., Micale, V., Navarria, A., & Drago, F. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.07.001 · Cited by 66 · see citing works
Influence of Vascular Endothelial Growth Factor Variation on Human Hippocampus Morphology
Blumberg, H. P., Wang, F., Chepenik, L. G., Kalmar, J. H., Edmiston, E. K., Duman, R. S., & Gelernter, J. E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.07.003 · Cited by 63 · see citing works
[VEGF as an angiogenic, neurotrophic, and neuroprotective factor].
Namiecińska, M., Marciniak, K., & Nowak, J. Z. (2005) · PubMed · Cited by 62 · see citing works
Differential brain, but not serum VEGF levels in a genetic rat model of depression
Elfving, B., Plougmann, P. H., & Wegener, G. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.02.063 · Cited by 61 · see citing works
Distribution of Flk‐1 and Flt‐1 receptors in neonatal and adult rat brains
Yang, S., Zhang, L., Huang, Y., & Sun, F. (2003) · The Anatomical Record Part A Discoveries in Molecular Cellular and Evolutionary Biology · doi:10.1002/ar.a.10103 · Cited by 57 · see citing works
Micale, V., Leggio, G. M., Mazzola, C., & Drago, F. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.108 · Cited by 46 · see citing works
McCloskey, D. P., Hintz, T. M., & Scharfman, H. E. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.11.018 · Cited by 32 · see citing works
Mani, N., Khaibullina, A., Krum, J. M., & Rosenstein, J. M. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22197 · Cited by 32 · see citing works
Tsai, S., Hong, C., Liou, Y., Chen, T., Chen, M., Hou, S.-J., Yen, F.-C., & Yu, Y. W. ‐. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.06.028 · Cited by 29 · see citing works
Bałan, B. J. (2008) · Cited by 24 · see citing works
Antidepressant hyperforin up-regulates VEGF in CNS tumour cells
Tassone, E., Maran, C., Masola, V., et al. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.09.005 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
Levy, M. J. F., Boulle, F., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., & Lanfumey, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4950-4 · Cited by 308 · see citing works
An astroglial basis of major depressive disorder? An overview
Wang, Q., Jie, W., Liu, J., Yang, J., & Gao, T. (2017) · Glia · doi:10.1002/glia.23143 · Cited by 222 · see citing works
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145 · see citing works
Nrf2 participates in depressive disorders through an anti-inflammatory mechanism
Martín-de-Saavedra, M. D., Budni, J., Cunha, M. P., Gómez-Rangel, V., Lorrio, S., del Barrio, L., Lastres-Becker, I., Parada, E., Tordera, R. M., Rodrigues, A. L. S., et al. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.03.020 · Cited by 143 · see citing works
Sharma, A. N., da Costa e Silva, B. F. B., Soares, J. C., Carvalho, A. F., & Quevedo, J. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.067 · Cited by 142 · see citing works
Walker, W. H., Borniger, J. C., Gaudier-Diaz, M. M., Hecmarie Meléndez-Fernández, O., Pascoe, J. L., Courtney DeVries, A., & Nelson, R. J. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0430-4 · Cited by 129 · see citing works
Deyama, S., Bang, E., Kato, T., Li, X.-Y., & Duman, R. S. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.12.014 · Cited by 116 · see citing works
VEGF and depression: A comprehensive assessment of clinical data
Clark-Raymond, A., & Halaris, A. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.04.008 · Cited by 108 · see citing works
Huynh, M. B., Ouidja, M. O., Chantepie, S., Carpentier, G., Maïza, A., Zhang, G., Vilares, J., Raisman-Vozari, R., & Papy-Garcia, D. (2019) · PLOS ONE · doi:10.1371/journal.pone.0209573 · Cited by 69 · see citing works
Wallensten, J., Mobarrez, F., Åsberg, M., Borg, K., Beser, A., Wilczek, A., & Nager, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-96313-8 · Cited by 19 · see citing works
- Authors
- Nowacka, M. M., & Obuchowicz, E.
- Affiliations
- Medical University of Silesia (PL)
- Corresponding author
- Obuchowicz, Ewa
- ORCID
- Obuchowicz, Ewa
- Venue
- Neuropeptides
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 46
- Issue
- 1
- Pages
- 1-10
- ISSN
- 0143-4179 (ISSN-L)
- OpenAlex
- W2119513113
- Cited by
- 157
- References
- 70
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 10 · 2023: 7 · 2022: 16 · 2021: 9 · 2020: 11 · 2019: 12 · 2018: 14 · 2017: 8 · 2016: 11 · 2015: 12 · 2014: 11 · 2013: 14 · 2012: 9
- FWCI
- 1.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropeptides (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- vascular endothelial growth factor, neurotrophic hypothesis, VEGFR2 signaling, VEGFR1, VEGFR-3, angiogenesis, neurogenesis, hippocampus, depression, neuroprotection, Schwann cells, astrocytes, microglia, neural progenitor cells, neuropsychiatric disorders, psychotropic drugs
- MeSH terms
- Animals, Antidepressive Agents, Cell Differentiation, Central Nervous System, Humans, Nerve Growth Factors, Neuronal Plasticity, Neurons, Signal Transduction, Neuroprotective Agents, Vascular Endothelial Growth Factor Receptor-1, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Endothelial Cells, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
